Article Menu
Need Help?
No Article Versions Notes Found
Cite
Cincilevičiūtė, G.; Averjanovaitė, V.; Mereškevičienė, R.; Pliatkienė, G.; Zablockis, R.; Danila, E. Risk Factors for Complicated Community-Acquired Pneumonia Course in Patients Treated with β-Lactam Monotherapy. Adv. Respir. Med. 2021, 89, 359-368. https://doi.org/10.5603/ARM.a2021.0070
Cincilevičiūtė G, Averjanovaitė V, Mereškevičienė R, Pliatkienė G, Zablockis R, Danila E. Risk Factors for Complicated Community-Acquired Pneumonia Course in Patients Treated with β-Lactam Monotherapy. Advances in Respiratory Medicine. 2021; 89(4):359-368. https://doi.org/10.5603/ARM.a2021.0070
Chicago/Turabian StyleCincilevičiūtė, Giedrė, Vaida Averjanovaitė, Rūta Mereškevičienė, Gabrielė Pliatkienė, Rolandas Zablockis, and Edvardas Danila. 2021. "Risk Factors for Complicated Community-Acquired Pneumonia Course in Patients Treated with β-Lactam Monotherapy" Advances in Respiratory Medicine 89, no. 4: 359-368. https://doi.org/10.5603/ARM.a2021.0070
APA StyleCincilevičiūtė, G., Averjanovaitė, V., Mereškevičienė, R., Pliatkienė, G., Zablockis, R., & Danila, E. (2021). Risk Factors for Complicated Community-Acquired Pneumonia Course in Patients Treated with β-Lactam Monotherapy. Advances in Respiratory Medicine, 89(4), 359-368. https://doi.org/10.5603/ARM.a2021.0070
